These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

405 related items for PubMed ID: 10939029

  • 1. Comparative study of the efficacy and tolerability of policosanol and lovastatin in patients with hypercholesterolemia and noninsulin dependent diabetes mellitus.
    Crespo N, Illnait J, Más R, Fernández L, Fernández J, Castaño G.
    Int J Clin Pharmacol Res; 1999; 19(4):117-27. PubMed ID: 10939029
    [Abstract] [Full Text] [Related]

  • 2. Effects of policosanol and lovastatin on lipid profile and lipid peroxidation in patients with dyslipidemia associated with type 2 diabetes mellitus.
    Castaño G, Menéndez R, Más R, Amor A, Fernández JL, González RL, Lezcay M, Alvarez E.
    Int J Clin Pharmacol Res; 2002; 22(3-4):89-99. PubMed ID: 12837046
    [Abstract] [Full Text] [Related]

  • 3. Effects of policosanol and pravastatin on lipid profile, platelet aggregation and endothelemia in older hypercholesterolemic patients.
    Castaño G, Más R, Arruzazabala ML, Noa M, Illnait J, Fernández JC, Molina V, Menéndez A.
    Int J Clin Pharmacol Res; 1999; 19(4):105-16. PubMed ID: 10939028
    [Abstract] [Full Text] [Related]

  • 4. Effects of policosanol 20 versus 40 mg/day in the treatment of patients with type II hypercholesterolemia: a 6-month double-blind study.
    Castaño G, Mas R, Fernández L, Illnait J, Gámez R, Alvarez E.
    Int J Clin Pharmacol Res; 2001; 21(1):43-57. PubMed ID: 11708574
    [Abstract] [Full Text] [Related]

  • 5. Comparison of the efficacy, safety and tolerability of original policosanol versus other mixtures of higher aliphatic primary alcohols in patients with type II hypercholesterolemia.
    Castaño G, Fernández L, Mas R, Illnait J, Fernández J, Mesa M, Alvarez E, Lezcay M.
    Int J Clin Pharmacol Res; 2002; 22(2):55-66. PubMed ID: 12503776
    [Abstract] [Full Text] [Related]

  • 6. A comparative study of policosanol Versus acipimox in patients with type II hypercholesterolemia.
    Alcocer L, Fernández L, Campos E, Más R.
    Int J Tissue React; 1999; 21(3):85-92. PubMed ID: 10645516
    [Abstract] [Full Text] [Related]

  • 7. Efficacy and tolerability of policosanol in hypercholesterolemic postmenopausal women.
    Mirkin A, Mas R, Martinto M, Boccanera R, Robertis A, Poudes R, Fuster A, Lastreto E, Yañez M, Irico G, McCook B, Farré A.
    Int J Clin Pharmacol Res; 2001; 21(1):31-41. PubMed ID: 11708573
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Effects of policosanol in patients with type II hypercholesterolemia and additional coronary risk factors.
    Más R, Castaño G, Illnait J, Fernández L, Fernández J, Alemán C, Pontigas V, Lescay M.
    Clin Pharmacol Ther; 1999 Apr; 65(4):439-47. PubMed ID: 10223782
    [Abstract] [Full Text] [Related]

  • 10. Concomitant use of policosanol and beta-blockers in older patients.
    Castaño G, Mas R, Gámez R, Fernández J, Illnait J, Fernández L, Mendoza S, Mesa M, Gutiérrez JA, López E.
    Int J Clin Pharmacol Res; 2004 Apr; 24(2-3):65-77. PubMed ID: 15689053
    [Abstract] [Full Text] [Related]

  • 11. [Comparative effects of policosanol and two HMG-CoA reductase inhibitors on type II hypercholesterolemia].
    Prat H, Román O, Pino E.
    Rev Med Chil; 1999 Mar; 127(3):286-94. PubMed ID: 10436712
    [Abstract] [Full Text] [Related]

  • 12. Comparison of the short term efficacy and tolerability of lovastatin and simvastatin in the management of primary hypercholesterolemia.
    Frohlich J, Brun LD, Blank D, Campeau L, Crockford P, Curnew G, Dafoe W, Davignon J, Dufour R, Emery G.
    Can J Cardiol; 1993 Jun; 9(5):405-12. PubMed ID: 8348392
    [Abstract] [Full Text] [Related]

  • 13. Comparative lipid-lowering effects of policosanol and atorvastatin: a randomized, parallel, double-blind, placebo-controlled trial.
    Cubeddu LX, Cubeddu RJ, Heimowitz T, Restrepo B, Lamas GA, Weinberg GB.
    Am Heart J; 2006 Nov; 152(5):982.e1-5. PubMed ID: 17070175
    [Abstract] [Full Text] [Related]

  • 14. Effects of successive dose increases of policosanol on the lipid profile of patients with type II hypercholesterolaemia and tolerability to treatment.
    Pons P, Rodríguez M, Robaina C, Illnait J, Más R, Fernández L, Fernández JC.
    Int J Clin Pharmacol Res; 1994 Nov; 14(1):27-33. PubMed ID: 7927958
    [Abstract] [Full Text] [Related]

  • 15. [A randomized, double-blind, placebo-controlled study of the antilipemic efficacy and tolerability of food supplement policosanol in patients with moderate hypercholesterolemia].
    Tedeschi-Reiner E, Reiner Z, Romić Z, Ivanković D.
    Lijec Vjesn; 2005 Nov; 127(11-12):273-9. PubMed ID: 16583932
    [Abstract] [Full Text] [Related]

  • 16. Policosanol: a new treatment for cardiovascular disease?
    Janikula M.
    Altern Med Rev; 2002 Jun; 7(3):203-17. PubMed ID: 12126462
    [Abstract] [Full Text] [Related]

  • 17. A 52-week, randomized, open-label, parallel-group comparison of the tolerability and effects of pitavastatin and atorvastatin on high-density lipoprotein cholesterol levels and glucose metabolism in Japanese patients with elevated levels of low-density lipoprotein cholesterol and glucose intolerance.
    Sasaki J, Ikeda Y, Kuribayashi T, Kajiwara K, Biro S, Yamamoto K, Ageta M, Kobori S, Saikawa T, Otonari T, Kono S.
    Clin Ther; 2008 Jun; 30(6):1089-101. PubMed ID: 18640465
    [Abstract] [Full Text] [Related]

  • 18. A two-year study on the efficacy and tolerability of policosanol in patients with type II hyperlipoproteinaemia.
    Canetti M, Moreira M, Mas R, Illnait J, Fernandez L, Fernandez J, Diaz E, Castano G.
    Int J Clin Pharmacol Res; 1995 Jun; 15(4):159-65. PubMed ID: 8871266
    [Abstract] [Full Text] [Related]

  • 19. Effect of sugar cane policosanol on lipid profile in primary hypercholesterolemia.
    Francini-Pesenti F, Beltramolli D, Dall'acqua S, Brocadello F.
    Phytother Res; 2008 Mar; 22(3):318-22. PubMed ID: 18167048
    [Abstract] [Full Text] [Related]

  • 20. Sugar cane policosanol failed to lower plasma cholesterol in primitive, diet-resistant hypercholesterolaemia: a double blind, controlled study.
    Francini-Pesenti F, Brocadello F, Beltramolli D, Nardi M, Caregaro L.
    Complement Ther Med; 2008 Apr; 16(2):61-5. PubMed ID: 18514906
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 21.